Gamma secretase inhibitors

Details for Australian Patent Application No. 2003210865 (hide)

Owner Schering Corporation Pharmacopeia, Inc.

Inventors Asberom, Theodros; Smith, Elizabeth M; Pissarnitski, Dmitri A; Clader, John W; Guo, Tao; Josien, Hubert B; Hobbs, Douglas W.

Agent Griffith Hack

Pub. Number AU-B-2003210865

PCT Number PCT/US03/03471

PCT Pub. Number WO2003/066592

Priority 60/355,618 06.02.02 US

Filing date 5 February 2003

Wipo publication date 2 September 2003

Acceptance publication date 31 January 2008

International Classifications

C07D 491/113 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4535 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/355,618 06.02.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-B-2003210865

21 October 2004 Assignment before Grant

  Schering Corporation; Pharmacopeia, Inc. The application has been assigned to Schering Corporation; Pharmacopeia Drug Discovery, Inc. Assignments before Grant, Section 113

13 September 2007 Assignment before Grant

  Schering Corporation; Pharmacopeia Drug Discovery, Inc. The application has been assigned to Schering Corporation; Pharmacopeia, Inc.

31 January 2008 Application Accepted

  Published as AU-B-2003210865

29 May 2008 Standard Patent Sealed

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210866-REDUCED POLARIZATION MODE DISPERSION FIBER

2003210864-THIRTY-DEGREE LENGTH IMPEDANCE TRANSFORMER